相关实验视频

Updated: Jul 1, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

表皮性途径可以驱动HIV-1从整合酶链转移抑制剂中逃脱

Yuta Hikichi¹, Jonathan R Grover², Alicia Schäfer²

¹Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.

Science advances

|March 1, 2024

概括

人类免疫缺陷病毒 (HIV) 可以通过病毒包膜蛋白的突变对整合酶链转移抑制剂 (INSTIs) 产生抗性,而不仅仅是整合酶标. 这增强了细胞间的传播,增加了病毒载量和耐药性.

科学领域:

病毒学病毒学
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

整合酶链转移抑制剂 (INSTIs) 对人类免疫缺陷病毒 (HIV) 治疗至关重要.
在INSTIs患者中观察到病毒学失败,在整合酶中没有可检测的抗性突变.
了解替代性耐药机制对于有效的HIV治疗至关重要.

研究的目的:

调查HIV-1在没有整合酶突变的情况下对INSTIs,特别是多卢特格拉维尔产生耐药性的机制.
阐明病毒包膜糖蛋白 (Env) 和核蛋白突变在INSTI耐药性中的作用.
确定这些突变如何影响病毒传播和药物易感性.

主要方法:

在体外传播HIV-1的过程中,杜洛特格拉维尔度不断升高.
测序病毒基因以识别获得的突变.
评估突变对病毒细胞转移和感染性的影响.
对INSTIs和其他抗逆转录病毒类别进行药物耐药性概况的评估.

主要成果:

艾滋病毒-1在Env和核囊蛋白中获得了序列突变,导致了多卢特格拉维尔耐药性.
恩维突变通过增加感染的多重性 (MOI) 显著增强了细胞间病毒传播.
这些突变赋予了广泛的抗逆转录病毒耐药性,与其他药物类别相比,对INSTIs的耐药性高出约2倍.
发现INSTI更容易被高MOI条件所压倒.

结论:

艾滋病毒-1可以通过独立于直接药物向突变的机制对强有力的INSTI产生耐药性.
增强病毒传播的突变和MOI在克服INSTI疗效方面发挥着重要作用.
这些发现为HIV-1抗逆转录病毒耐药性演变提供了新的见解,特别是在高病毒活性条件下.

更多相关视频

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...